Nanomedicine for diabetes treatment

Nanomedicine

Volumn 6, Issue 8, 2011, Pages 1297-1300

  Sung, Hsing Wen ^a   Sonaje, Kiran ^a   Feng, Si Shen ^b  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

chitosan nanoparticles; diabetic complications; oral insulin delivery; pH sensitive nanoparticles

Indexed keywords

9 FLUORENYLMETHYL CHLOROFORMATE; CHITOSAN; DOCETAXEL; DRUG VEHICLE; INSULIN; MACROGOL; NANOPARTICLE; POLYCAPROLACTONE; POLYGLYCOLIC ACID; POLYMER;

DIABETES MELLITUS; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; HUMAN; MEDICAL RESEARCH; NANOMEDICINE; NANOTECHNOLOGY; NONHUMAN; PH; PHARMACODYNAMICS; PRIORITY JOURNAL; REVIEW;

DIABETES MELLITUS; DRUG CARRIERS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; NANOMEDICINE; NANOPARTICLES;

EID: 80155211212     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.11.124     Document Type: Review

References (27)

1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 87(1), 4-14 (2010).
2. Carino GP, Mathiowitz E. Oral insulin delivery. Adv. Drug Del. Rev. 35(2-3), 249-257 (1999).
3. Clore J, Thurby-Hay L. Basal insulin therapy. Curr. Diab. Rep. 4(5), 342-345 (2004).
4. Arbit E, Kidron M. Oral insulin: the rationale for this approach and current developments. J. Diabetes Sci. Technol. 3(3), 562-567 (2009).
5. Binder C, Lauritzen T, Faber O, Pramming S. Insulin pharmacokinetics. Diabetes Care 7(2), 188-199 (1984).
6. Ward PD, Tippin TK, Thakker DR. Enhancing paracellular permeability by modulating epithelial tight junctions. Pharm. Sci. Tech. Today 3(10), 346-358 (2000).
7. Feng SS. New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now? Nanomedicine (Lond.) 1(3), 297-309 (2006).
8. Feng SS. Nanomedicine: nanoparticles of biodegradable polymers for cancer diagnosis and treatment. COSMOS - Interdiscipl. J. Sci. Singa. Natl Acad. Sci. 4(2), 185-201 (2008).
9. Gershonov E, Goldwaser I, Fridkin M, Shechter Y. A novel approach for a water-soluble long-acting insulin prodrug: design, preparation, and analysis of [(2-sulfo)-9-fluorenylmethoxycarbonyl]3-insulin. J. Med. Chem. 43(13), 2530-2537 (2000).
10. Calceti P, Salmaso S, Walker G, Bernkop-Schnrch A. Development and in vivo evaluation of an oral insulin-PEG delivery system. Eur. J. Pharm. Sci. 22(4), 315-323 (2004).
11. Scott-Moncrieff JC, Shao Z, Mitra AK. Enhancement of intestinal insulin absorption by bile salt-fatty acid mixed micelles in dogs. J. Pharm. Sci. 83(10), 1465-1469 (1994).
12. Wang B, Ma R, Liu G et al. Glucose-Responsive micelles from self-assembly of poly(ethylene glycol)-b-poly(acrylic acid-co-acrylamidophenylboronic acid) and the controlled release of insulin. Langmuir 25(21), 12522-12528 (2009).
13. Niu M, Lu Y, Hovgaard L, Wu W. Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation. Int. J. Nanomed. 6(1), 1155-1166(2011).
14. Cui FD, Tao AJ, Cun DM, Zhang LQ, Shi K. Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery. J. Pharm. Sci. 96(2), 421-427 (2007).
15. Ramesan RM, Sharma CP. Challenges and advances in nanoparticle-based oral insulin delivery. Expert Rev. Med. Devices 6(6), 665-676(2009).
16. Feng SS, Zhao L, Tang J. Nanomedicine for oral chemotherapy. Nanomedicine (Lond.) 6(3), 407-410 (2011).
17. Chaudhury A, Das S. Recent Advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents. AAPS Pharm. Sci. Tech. 12(1), 10-20 (2011).
18. Yeh TH, Hsu LW, Tseng MT et al. Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening. Biomaterials 32(26), 6164-6173 (2011).
19. Sonaje K, Lin K-J, Wang JJ et al. Self-assembled pH-sensitive nanoparticles: a platform for oral delivery of protein drugs. Adv. Funct. Mater 20(21), 3695-3700 (2010).
20. Lin YH, Chung CK, Chen CT, Liang HF, Chen SC, Sung HW. Preparation of nanoparticles composed of chitosan/ poly-r-glutamic acid and evaluation of their permeability through Caco-2 Cells. Biomacromolecules 6(2), 1104-1112 (2005).
21. Lin YH, Mi FL, Chen CT et al. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery. Biomacromolecules 8(1), 146-152 (2007).
22. Sonaje K, Lin YH, Juang JH, Wey SP, Chen CT, Sung HW. In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery. Biomaterials 30(12), 2329-2339 (2009).
23. Yin L, Ding J, He C, Cui L, Tang C, Yin C. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. Biomaterials 30(29), 5691-5700 (2009).
24. Sonaje K, Chen YJ, Chen HL et al. Enteric-coated capsules filled with freeze-dried chitosan/poly(g-glutamic acid) nanoparticles for oral insulin delivery. Biomaterials 31(12), 3384-3394 (2010).
25. Sonaje K, Lin KJ, Wey SP et al. Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: oral delivery using pH-responsive nanoparticles vs. subcutaneous injection. Biomaterials 31(26), 6849-6858 (2010).
26. Arbit E. The physiological rationale for oral insulin administration. Diabetes Technol. Ther. 6(4), 510-517 (2004).
27. Gossain V. Insulin analogs and intensive insulin therapy in Type 1 diabetes. Int. J. Diabetes Dev. Ctries. 23(2), 26-36(2003).